DanGer Shock - First Positive RCT of Impella - Cardiogenic Shock - A critical appraisal

Поделиться
HTML-код
  • Опубликовано: 6 фев 2025
  • Vinay Prasad, MD MPH; Physician & Professor
    Hematologist/ Oncologist
    Professor of Epidemiology, Biostatistics and Medicine
    Author of 450+ Peer Reviewed papers, 2 Books, 2 Podcasts, 100+ op-eds.
    If you want to contact me, do it here: www.vinayakkpra...
    Google Scholar: scholar.google...
    Substack: vinayprasadmdm...
    Podcast: podcasts.apple...
    Personal Website: www.vinayakkprasad.com
    Laboratory Website: www.vkprasadlab.com
    Podcast Website: www.plenarysessionpodcast.com
    Academic Publications: www.vinayakkpra...
    Follow me on:
    Twitter @vprasadmdmph

Комментарии • 46

  • @LTzEz03z
    @LTzEz03z 8 месяцев назад +1

    Clinical Specialist in industry with Cath Lab Specialist background. Great Video. Been a big Impella “believer” but glad to see you run this video. Thank you.

  • @AineTheAnamCara
    @AineTheAnamCara 9 месяцев назад +39

    Dr. Prasad, while I’m completely disgusted with unethical researchers that willingly harm patients in order to achieve a positive endpoint, I absolutely LOVE seeing how passionate and quippy you are when you’re calling out unethical researchers and the absolutely nausea inducing research they shamelessly produce.❤

    • @dedetudor.
      @dedetudor. 9 месяцев назад +2

      I agree. I love his delivery.

    • @Fortune-z1i
      @Fortune-z1i 9 месяцев назад +1

      He is a money-making charlatan - at his worst when vilifying his profession. He disgusts most decent people.

    • @hmbdata
      @hmbdata 9 месяцев назад

      @@Fortune-z1i Got an example?

    • @DylanYoung
      @DylanYoung 9 месяцев назад

      He certainly "disgusts" the charlatans trying to make money or advance their careers off of desperate sick people by selling them snake oil, doesn't he user-rx5vo3nt4z? ;)

    • @NEILANIL1
      @NEILANIL1 9 месяцев назад

      ​@user-rx5vo3nt4z who you talking about dr. Prasad?

  • @walterbortz355
    @walterbortz355 9 месяцев назад +5

    VP- you are going deeper into the statistical nuance these days and there ain’t nuthin wrong with that! It’s up to the listener to try to follow your analysis and hopefully it will begin to make more sense. Keep up your important work!

  • @brianwinger524
    @brianwinger524 9 месяцев назад +10

    Dr. Prasad, I would love to see a video on how you teach statistics (Bayesian vs. frequentist). Why the “0.05” can be misleading. Thanks for all your content!

  • @Luke-mr4ew
    @Luke-mr4ew 9 месяцев назад +6

    Erm, low-GCS STEMI patients I&V are exactly the group that we'd want to see the intervention for. The baseline survival rate is so low, an improved survival should be very sensitive to detect.

  • @DrJuanTaco
    @DrJuanTaco 9 месяцев назад +17

    Pump failure is consistently the most difficult form of shock to deal with. Furthermore, you need the patient to be able to survive getting to these procedures in addition to all of the multifactorial of acute heart failure. You said it best yourself, they're selecting all of the "bad" patients out of their patient cohorts and thus biasing the result.

  • @daviddobies2993
    @daviddobies2993 7 месяцев назад

    Great points. Thanks for the review. I agree.

  • @biodivers5294
    @biodivers5294 9 месяцев назад +1

    Great view on relevance!

  • @ningayeti
    @ningayeti 9 месяцев назад +7

    I am a retired CCRN. I worked pediatric ICU for 32 years at a level 1 trauma and transplant center.
    In the 80's and 90's I ran IAPB on dozens of patients. In those 32 years I have also ran ECMO on hundreds of patients as well as VADs on several others. I don't know about adult post MI or acute cardiomyopathy patients, but I can tell you that the great majority of our ECMO patients made it to discharge even after being on ECMO for weeks in some cases. Again; these are pediatric patients with a wide variety of cardiac insults both congenital and acquired.

    • @gracefullstitcher4707
      @gracefullstitcher4707 9 месяцев назад

      Retired PICU RN at a large teaching hospital. We had tons of post-op cardiac patients, lots of ECMO. Not a lot of transplants but the ones we cared for did great. Loved my years in the PICU. The current state of scientific research is very concerning.

  • @vickibennett8297
    @vickibennett8297 9 месяцев назад

    I have learned in the last year just how little it feels like the drug studies are about the patients at all! My 16 year old granddaughter was diagnosed with DMG , she had radiation, then was told she didn’t qualify for any trials. Because she didn’t fit perfectly in the narrow qualifications! We were told when she had tumor progression she could be in a slow the tumor trial. Now the hospital nearest to her…which is 3+ hours away isn’t taking patients. She may only have weeks left, and they aren’t taking patients! It really is all about getting their drug to market….not about saving lives!

  • @ImNoclue
    @ImNoclue 9 месяцев назад +2

    What’s the over/under on years to medical reversal for this protocol?

  • @hmbdata
    @hmbdata 9 месяцев назад +6

    And here I am thinking psychologists do shady studies!

  • @nancyt61
    @nancyt61 9 месяцев назад +2

    Can you comment on Dr Geert Vanden Bossche theory on increasing covid virulence virus is coming ? Is it crap or its plausible ? Sorry for being off topic.

  • @jeyrozs23
    @jeyrozs23 3 месяца назад +1

    I find it difficult to see the relevance of your arguments. Yes, they did exclude many patients, but what were you expecting? If previous studies yielded negative results by choosing a very broad population, including patients with extremely severe pathologies, then it’s logical to focus on a more selective population with an inherently better prognosis.
    In the case of out-of-hospital cardiac arrests, we're dealing with a group of patients with a highly severe prognosis. Their outlook is primarily driven-outside ST+ cases-by neurological rather than cardiovascular status (with a median time in the ecls trial of 20 min before resuscitation). Moreover, post-resuscitation cardiac dysfunction doesn’t operate under the same mechanisms as cardiogenic shock, as there's a significant contribution of vasoplegia related to the systemic inflammatory response after resuscitation, whereas mechanical support works among other things by reducing afterload. They btw didn’t exclude patients who suffered out-of-hospital cardiac arrests if they had a Glasgow score >8.
    So how would excluding these cardiac arrest cases be a “huge mistake,” as you put it? Wasn’t the real error in including these patients, for whom the lack of benefit was foreseeable?
    This study focuses on a specific category of patients with cardiovascular dysfunction related to acute coronary syndrome, not systemic inflammation. This is a group we encounter frequently in clinical practice. The goal here isn’t to show that Impella or counterpulsation works for all patients in shock, but rather to identify which patient profiles are most likely to respond.
    Remember, the MitraFR study found no benefit from the MitraClip, whereas COAPT showed a significant positive effect. The same treatment can vary when baseline prognosis differs due to the severity of the pathology.

  • @westfield90
    @westfield90 9 месяцев назад +3

    I’m so frustrated with the state of medical research. Too much effort is expended creating a study to fit the outcome they desire. Too many patients excluded and too many variables slotted to fit a narrative.

  • @mashleymorgan
    @mashleymorgan 9 месяцев назад

    What happened to the VPZD Show?!? Man, those were some great episodes... Keep up the informative push-back against bad medical data!

    • @TREANIEBEAN
      @TREANIEBEAN 9 месяцев назад

      I don’t know what happened with VPZD show, but when this episode aired I wondered if VP would distance himself. Alas no show since.
      ruclips.net/user/liveaO6_-79bMEQ?si=qDdBslaGoR4rwIQL

    • @tallard666
      @tallard666 7 месяцев назад

      There was one recent episode, but it was rather not as entertaining as SCV2 days. Ultimately, z is no longer practicing, makes him less relevant.

  • @WeighedWilson
    @WeighedWilson 9 месяцев назад

    Let a clever person design the study and you will get whatever result you want.

  • @arubaga
    @arubaga 9 месяцев назад

    I keep thinking they know the randomization is reversible, and they merely worsened the outcomes in the control group.

  • @marchhair01
    @marchhair01 9 месяцев назад +6

    Company-sponsored clinical trials occur for one reason - to make the company money.

    • @riccochet1
      @riccochet1 7 месяцев назад +1

      This was an independent study

  • @derpmcghee
    @derpmcghee 9 месяцев назад +1

    Thoughts on the effect on medicine if the p value for the medical field was raised to the 5-sigma required in physics? Good or bad?

    • @skaterkraines2691
      @skaterkraines2691 9 месяцев назад +3

      Say goodbye to 90 percent of pharmaceuticals, I'm guessing

    • @dedetudor.
      @dedetudor. 9 месяцев назад

      ​@@skaterkraines2691when nearly all of their drug commercials end in cancer and even death... That's pretty darn scary. And look at the definition of synthetic biology from May 22, 2017.

  • @olibertosoto5470
    @olibertosoto5470 9 месяцев назад

    So what are you trying to say about the state of evidence based medicine?

  • @boohoo5750
    @boohoo5750 9 месяцев назад

    😊

  • @sherry3661
    @sherry3661 8 месяцев назад +1

    I’m tired of the excuses… I don’t want to be a nurse anymore….😞

  • @Photoshop729
    @Photoshop729 9 месяцев назад

    First comment! 2 seconds in…not sure where this is going yet.

  • @nancienordwick4169
    @nancienordwick4169 9 месяцев назад +1

    You have just torn apart the study by finding a difference between the control arm and the intervention populations other than the intervention, itself. Sigh. Even if it started out randomly assigned, the authors can't say their intervention was the cause of the slight but statistically significant effect. This should never have passed an initial peer review.

  • @carlosgaspar8447
    @carlosgaspar8447 9 месяцев назад

    if you don't agree with this study, then you really ain't a peer!

  • @ziaulislam87
    @ziaulislam87 2 месяца назад

    Very biased take.

  • @mballer
    @mballer 9 месяцев назад

    You talk too much.

    • @Andy_T79
      @Andy_T79 9 месяцев назад +5

      ... you waste organs, air, battery charge.

    • @TheresaGraf
      @TheresaGraf 9 месяцев назад +5

      Why tune in if you have that attitude?

    • @mballer
      @mballer 9 месяцев назад +2

      @@TheresaGraf
      I'm addicted.

    • @mballer
      @mballer 9 месяцев назад +1

      @@Andy_T79
      True

  • @ziaulislam87
    @ziaulislam87 2 месяца назад

    Very biased take.